As of 2024-07-27, the EV/EBITDA ratio of ImmunoGen Inc (IMGN) is -105.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMGN's latest enterprise value is 8,216.60 mil USD. IMGN's TTM EBITDA according to its financial statements is -77.98 mil USD. Dividing these 2 quantities gives us the above IMGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 21.5x | 16.6x |
| Forward P/E multiples | 17.8x - 24.1x | 21.4x |
| Fair Price | (3.15) - (4.18) | (3.49) |
| Upside | -110.1% - -113.4% | -111.2% |
| Date | EV/EBITDA |